The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCE INC | COM | 00032Q104 | 44,919 | 1,529,402 | SH | SOLE | 1,529,402 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 82,151 | 4,563,962 | SH | SOLE | 4,563,962 | 0 | 0 | ||
AKOYA BIOSCIENCES INC | COM | 00974H104 | 5,584 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
ALTIMMUNE INC | COM | 02155H200 | 42,978 | 3,800,000 | SH | SOLE | 3,800,000 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 4,765 | 538,999 | SH | SOLE | 538,999 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 11,220 | 1,196,196 | SH | SOLE | 1,196,196 | 0 | 0 | ||
ATYR PHARMA INC | COM | 002120202 | 14,210 | 1,565,000 | SH | SOLE | 1,565,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC | COM | 15117B202 | 59,290 | 1,098,174 | SH | SOLE | 1,098,174 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONS ADR | 152309100 | 18,825 | 1,127,272 | SH | SOLE | 1,127,272 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 9,157 | 1,088,817 | SH | SOLE | 1,088,817 | 0 | 0 | ||
CORVUS PHARMACEUTICALS INC | COM | 221015100 | 16,589 | 3,427,461 | SH | SOLE | 3,427,461 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 15,936 | 706,050 | SH | SOLE | 706,050 | 0 | 0 | ||
CVRX INC | COM | 126638105 | 8,822 | 533,370 | SH | SOLE | 533,370 | 0 | 0 | ||
GH RESEARCH PLC | ORD SH | G3855L106 | 36,229 | 1,642,296 | SH | SOLE | 1,642,296 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 26,431 | 1,612,617 | SH | SOLE | 1,612,617 | 0 | 0 | ||
INSTIL BIO INC | COM | 45783C101 | 122,713 | 6,865,076 | SH | SOLE | 6,865,076 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 33,909 | 1,473,014 | SH | SOLE | 1,473,014 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM | 56854Q200 | 30,064 | 2,641,809 | SH | SOLE | 2,641,809 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 18,129 | 803,951 | SH | SOLE | 803,951 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 42,337 | 1,536,193 | SH | SOLE | 1,536,193 | 0 | 0 | ||
PHARVARIS NV | COM | N69605108 | 9,803 | 552,882 | SH | SOLE | 552,882 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 36,372 | 1,387,720 | SH | SOLE | 1,387,720 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 42,011 | 1,732,410 | SH | SOLE | 1,732,410 | 0 | 0 | ||
TRICIDA INC | COM | 89610F101 | 1,813 | 390,707 | SH | SOLE | 390,707 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 321 | 19,495 | SH | SOLE | 19,495 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM | 92840H202 | 43,970 | 16,047,286 | SH | SOLE | 16,047,286 | 0 | 0 |